Coquerel D

References (2)

Title : Soluble Epoxide Hydrolase Inhibition Prevents Experimental Type 4 Cardiorenal Syndrome - Hamzaoui_2020_Front.Mol.Biosci_7_604042
Author(s) : Hamzaoui M , Roche C , Coquerel D , Duflot T , Brunel V , Mulder P , Richard V , Bellien J , Guerrot D
Ref : Front Mol Biosci , 7 :604042 , 2020
Abstract : Hamzaoui_2020_Front.Mol.Biosci_7_604042
ESTHER : Hamzaoui_2020_Front.Mol.Biosci_7_604042
PubMedSearch : Hamzaoui_2020_Front.Mol.Biosci_7_604042
PubMedID: 33777999

Title : Soluble epoxide hydrolase inhibition improves coronary endothelial function and prevents the development of cardiac alterations in obese insulin-resistant mice - Roche_2015_Am.J.Physiol.Heart.Circ.Physiol_308_H1020
Author(s) : Roche C , Besnier M , Cassel R , Harouki N , Coquerel D , Guerrot D , Nicol L , Loizon E , Remy-Jouet I , Morisseau C , Mulder P , Ouvrard-Pascaud A , Madec AM , Richard V , Bellien J
Ref : American Journal of Physiology Heart Circ Physiol , 308 :H1020 , 2015
Abstract : Roche_2015_Am.J.Physiol.Heart.Circ.Physiol_308_H1020
ESTHER : Roche_2015_Am.J.Physiol.Heart.Circ.Physiol_308_H1020
PubMedSearch : Roche_2015_Am.J.Physiol.Heart.Circ.Physiol_308_H1020
PubMedID: 25724490